WallStSmart

American Shared Hospital Service (AMS)vsFresenius Medical Care Corporation (FMS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Fresenius Medical Care Corporation generates 66529% more annual revenue ($19.36B vs $29.05M). FMS leads profitability with a 4.9% profit margin vs -5.3%. FMS earns a higher WallStSmart Score of 50/100 (C-).

AMS

Hold

36

out of 100

Grade: F

Growth: 6.0Profit: 2.0Value: 6.0Quality: 4.0
Piotroski: 4/9Altman Z: 0.97

FMS

Buy

50

out of 100

Grade: C-

Growth: 2.7Profit: 5.0Value: 9.3Quality: 6.0
Piotroski: 6/9Altman Z: 1.96
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

AMSUndervalued (+28.0%)

Margin of Safety

+28.0%

Fair Value

$3.18

Current Price

$1.33

$1.85 discount

UndervaluedFair: $3.18Overvalued
FMSUndervalued (+69.0%)

Margin of Safety

+69.0%

Fair Value

$77.65

Current Price

$22.03

$55.62 discount

UndervaluedFair: $77.65Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AMS2 strengths · Avg: 9.0/10
Price/BookValuation
0.4x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
15.9%8/10

15.9% revenue growth

FMS3 strengths · Avg: 9.3/10
P/E RatioValuation
11.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.8x10/10

Reasonable price relative to book value

PEG RatioValuation
0.798/10

Growing faster than its price suggests

Areas to Watch

AMS4 concerns · Avg: 2.3/10
Market CapQuality
$9.08M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-6.5%2/10

ROE of -6.5% — below average capital efficiency

EPS GrowthGrowth
-38.1%2/10

Earnings declined 38.1%

Altman Z-ScoreHealth
0.972/10

Distress zone — elevated risk

FMS4 concerns · Avg: 3.0/10
Altman Z-ScoreHealth
1.964/10

Grey zone — moderate risk

Return on EquityProfitability
7.1%3/10

ROE of 7.1% — below average capital efficiency

Profit MarginProfitability
4.9%3/10

4.9% margin — thin

Revenue GrowthGrowth
-5.5%2/10

Revenue declined 5.5%

Comparative Analysis Report

WallStSmart Research

Bull Case : AMS

The strongest argument for AMS centers on Price/Book, Revenue Growth. Revenue growth of 15.9% demonstrates continued momentum.

Bull Case : FMS

The strongest argument for FMS centers on P/E Ratio, Price/Book, PEG Ratio. PEG of 0.79 suggests the stock is reasonably priced for its growth.

Bear Case : AMS

The primary concerns for AMS are Market Cap, Return on Equity, EPS Growth.

Bear Case : FMS

The primary concerns for FMS are Altman Z-Score, Return on Equity, Profit Margin. Thin 4.9% margins leave little buffer for downturns.

Key Dynamics to Monitor

AMS profiles as a growth stock while FMS is a value play — different risk/reward profiles.

FMS carries more volatility with a beta of 0.81 — expect wider price swings.

AMS is growing revenue faster at 15.9% — sustainability is the question.

FMS generates stronger free cash flow (37M), providing more financial flexibility.

Bottom Line

FMS scores higher overall (50/100 vs 36/100). AMS offers better value entry with a 28.0% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

American Shared Hospital Service

HEALTHCARE · MEDICAL CARE FACILITIES · USA

American Shared Hospital Services rents radiosurgery and radiation therapy equipment to healthcare providers. The company is headquartered in San Francisco, California.

Fresenius Medical Care Corporation

HEALTHCARE · MEDICAL CARE FACILITIES · USA

Fresenius Medical Care AG & Co. KGaA provides dialysis care and related dialysis care services in Germany, North America and internationally. The company is headquartered in Bad Homburg, Germany.

Visit Website →

Want to dig deeper into these stocks?